Purchases and Sales Made in Q2 2025 in Esperion Therapeutics, Inc. (ESPR)
This table provides information about the institutional ownership of Esperion Therapeutics, Inc. (ESPR) during Q2 2025. The information is specifically focused on institutions that hold shares of Esperion Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2025
Q2 2025
|
Wasatch Advisors Inc
Salt Lake City, UT |
SELL
|
- |
-591K- 5.41% |
$431K - $833K
|
10.3M
$27.3M
|
|
|
Aug 27, 2025
Q2 2025
|
Squarepoint Ops LLC
New York, NY |
SELL
|
- |
-663K- 75.57% |
$484K - $935K
|
214K
$566K
|
|
|
Aug 14, 2025
Q2 2025
|
Squarepoint Ops LLC
New York, NY |
SELL
|
- |
-663K- 75.57% |
$484K - $935K
|
214K
$566K
|
|
|
Aug 14, 2025
Q2 2025
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-691K- 45.24% |
$504K - $974K
|
836K
$2.21M
|
|
|
Aug 14, 2025
Q2 2025
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-729K- 47.7% |
$532K - $1.03M
|
799K
$2.11M
|
|
|
Aug 14, 2025
Q2 2025
|
State Street Corp
Boston, MA |
SELL
|
- |
-790K- 17.36% |
$576K - $1.11M
|
3.76M
$9.92M
|
|
|
Aug 14, 2025
Q2 2025
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-903K- 33.07% |
$659K - $1.27M
|
1.83M
$4.83M
|
|
|
Aug 14, 2025
Q2 2025
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-1.09M- 89.86% |
$799K - $1.54M
|
123K
$326K
|
|
|
Aug 12, 2025
Q2 2025
|
Nuveen, LLC
Charlotte, NC |
SELL
|
- |
-2.67M- 86.31% |
$1.95M - $3.76M
|
423K
$1.12M
|
|
|
Aug 15, 2025
Q2 2025
|
Morgan Stanley
New York, NY |
SELL
|
- |
-5.53M- 83.98% |
$4.04M - $7.8M
|
1.06M
$2.79M
|